Vitrolife AB (publ) (VTRLY)
USD 18.0
(7.46%)
USD 18.0
(7.46%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.22 Billion SEK | -25.44% |
| 2022 | 1.64 Billion SEK | -11.09% |
| 2021 | 1.85 Billion SEK | 303.3% |
| 2020 | -911.16 Million SEK | -48.47% |
| 2019 | -613.69 Million SEK | -25.04% |
| 2018 | -490.81 Million SEK | -24.1% |
| 2017 | -395.48 Million SEK | -161.24% |
| 2016 | -151.38 Million SEK | 0.45% |
| 2015 | -152.06 Million SEK | -597.4% |
| 2014 | -21.8 Million SEK | -44.22% |
| 2013 | -15.11 Million SEK | -123.86% |
| 2012 | 63.37 Million SEK | 37.48% |
| 2011 | 46.09 Million SEK | 37.35% |
| 2010 | 33.56 Million SEK | 677.33% |
| 2009 | -5.81 Million SEK | 22.19% |
| 2008 | -7.47 Million SEK | -433.82% |
| 2007 | 2.23 Million SEK | 115.47% |
| 2006 | -14.47 Million SEK | 70.04% |
| 2005 | -48.29 Million SEK | -7.48% |
| 2004 | -44.93 Million SEK | 12.83% |
| 2003 | -51.54 Million SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 995 Million SEK | -9.42% |
| 2024 Q2 | 1.24 Billion SEK | 10.6% |
| 2024 Q1 | 1.12 Billion SEK | -8.55% |
| 2023 Q4 | 1.22 Billion SEK | -10.89% |
| 2023 Q2 | 1.58 Billion SEK | 3.25% |
| 2023 Q1 | 1.53 Billion SEK | -6.68% |
| 2023 FY | 1.22 Billion SEK | -25.44% |
| 2023 Q3 | 1.37 Billion SEK | -13.17% |
| 2022 Q3 | 1.74 Billion SEK | -8.0% |
| 2022 Q2 | 1.89 Billion SEK | 1.33% |
| 2022 Q4 | 1.64 Billion SEK | -5.72% |
| 2022 FY | 1.64 Billion SEK | -11.09% |
| 2022 Q1 | 1.87 Billion SEK | 1.17% |
| 2021 Q1 | -1.05 Billion SEK | -16.07% |
| 2021 FY | 1.85 Billion SEK | 303.3% |
| 2021 Q3 | -4.69 Billion SEK | -333.26% |
| 2021 Q4 | 1.85 Billion SEK | 139.45% |
| 2021 Q2 | -1.08 Billion SEK | -2.47% |
| 2020 Q1 | -640.78 Million SEK | -4.41% |
| 2020 Q4 | -911.16 Million SEK | -18.7% |
| 2020 Q3 | -767.63 Million SEK | -12.43% |
| 2020 FY | -911.16 Million SEK | -48.47% |
| 2020 Q2 | -682.75 Million SEK | -6.55% |
| 2019 Q3 | -520.49 Million SEK | -41.73% |
| 2019 FY | -613.69 Million SEK | -25.04% |
| 2019 Q1 | -445.2 Million SEK | 9.29% |
| 2019 Q4 | -613.69 Million SEK | -17.9% |
| 2019 Q2 | -367.23 Million SEK | 17.51% |
| 2018 Q4 | -490.81 Million SEK | 1.09% |
| 2018 Q1 | -398.8 Million SEK | -0.84% |
| 2018 FY | -490.81 Million SEK | -24.1% |
| 2018 Q2 | -421.39 Million SEK | -5.66% |
| 2018 Q3 | -496.22 Million SEK | -17.76% |
| 2017 Q4 | -395.48 Million SEK | -38.98% |
| 2017 FY | -395.48 Million SEK | -161.24% |
| 2017 Q3 | -284.56 Million SEK | -39.64% |
| 2017 Q2 | -203.78 Million SEK | -11.1% |
| 2017 Q1 | -183.42 Million SEK | -21.16% |
| 2016 Q4 | -151.38 Million SEK | -95.63% |
| 2016 Q1 | -157.32 Million SEK | -3.46% |
| 2016 Q2 | -32.55 Million SEK | 79.31% |
| 2016 FY | -151.38 Million SEK | 0.45% |
| 2016 Q3 | -77.38 Million SEK | -137.74% |
| 2015 Q2 | -7.55 Million SEK | 54.95% |
| 2015 Q1 | -16.76 Million SEK | 23.11% |
| 2015 Q4 | -152.06 Million SEK | -137.97% |
| 2015 FY | -152.06 Million SEK | -597.4% |
| 2015 Q3 | -63.9 Million SEK | -746.05% |
| 2014 Q3 | -91.87 Million SEK | -131.37% |
| 2014 Q1 | -31.1 Million SEK | -105.75% |
| 2014 FY | -21.8 Million SEK | -44.22% |
| 2014 Q4 | -21.8 Million SEK | 76.27% |
| 2014 Q2 | -39.7 Million SEK | -27.65% |
| 2013 Q4 | -15.11 Million SEK | -199.95% |
| 2013 Q2 | 46.25 Million SEK | -1.57% |
| 2013 Q3 | 15.12 Million SEK | -67.3% |
| 2013 Q1 | 46.99 Million SEK | -25.85% |
| 2013 FY | -15.11 Million SEK | -123.86% |
| 2012 Q3 | 433.24 Million SEK | 816.91% |
| 2012 Q1 | 36.65 Million SEK | -20.49% |
| 2012 Q2 | 47.25 Million SEK | 28.92% |
| 2012 Q4 | 63.37 Million SEK | -85.37% |
| 2012 FY | 63.37 Million SEK | 37.48% |
| 2011 FY | 46.09 Million SEK | 37.35% |
| 2011 Q4 | 46.09 Million SEK | -15.17% |
| 2011 Q2 | 56.51 Million SEK | 28.23% |
| 2011 Q1 | 44.07 Million SEK | 31.34% |
| 2011 Q3 | 54.34 Million SEK | -3.85% |
| 2010 Q3 | 6.11 Million SEK | 161.66% |
| 2010 FY | 33.56 Million SEK | 677.33% |
| 2010 Q2 | 2.33 Million SEK | 0.0% |
| 2010 Q4 | 33.56 Million SEK | 448.81% |
| 2009 Q4 | -5.81 Million SEK | 0.0% |
| 2009 FY | -5.81 Million SEK | 22.19% |
| 2008 FY | -7.47 Million SEK | -433.82% |
| 2007 FY | 2.23 Million SEK | 115.47% |
| 2006 FY | -14.47 Million SEK | 70.04% |
| 2005 FY | -48.29 Million SEK | -7.48% |
| 2004 FY | -44.93 Million SEK | 12.83% |
| 2003 FY | -51.54 Million SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| IR-Med Inc. | -606 Thousand USD | 202740.264% |
| Polarean Imaging plc | -5.94 Million USD | 20750.678% |
| Avitar, Inc. | 5.17 Million USD | -23647.103% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -566822.736% |
| CVR Medical Corp. | - USD | -Infinity% |
| AVITA Medical, Inc. | -26.23 Million USD | 4781.374% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 17542957.143% |
| Össur hf. | 395.08 Million USD | -210.823% |
| Zecotek Photonics Inc. | 2.76 Million USD | -44353.293% |
| QHSLab, Inc. | 1.72 Million USD | -70883.89% |
| Wellstar International, Inc. | 51.36 Million USD | -2290.643% |
| Össur hf. | 395.08 Million USD | -210.823% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 26696.373% |
| Escalon Medical Corp. | 315.68 Thousand USD | -388894.127% |
| Aurora Spine Corporation | 1.9 Million USD | -64272.227% |
| BrainsWay Ltd. | -10.32 Million USD | 11999.225% |
| BioElectronics Corporation | 14.82 Million USD | -8182.438% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | -50748.314% |
| Hamilton Thorne Ltd. | 18.12 Million USD | -6674.783% |
| Vivos Inc. | -1.59 Million USD | 77221.775% |
| MicroPort Scientific Corporation | 673.58 Million USD | -82.309% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -251883.756% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 227092.935% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -191715.957% |
| Nanomix Corporation | 11.38 Million USD | -10682.185% |
| Theraclion SA | -5.86 Million EUR | 21039.427% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | -30711.824% |
| Positron Corporation | 1.68 Million USD | -72697.117% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -76133.423% |
| Lombard Medical, Inc. | 11.49 Million USD | -10582.906% |
| ALR Technologies Inc. | 19.14 Million USD | -6313.12% |
| Stratec SE | 119.12 Million USD | -930.856% |
| Vycor Medical, Inc. | 1.05 Million USD | -116523.946% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -2232830.266% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -1317581.396% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 9006.759% |
| SANUWAVE Health, Inc. | 30.14 Million USD | -3973.374% |
| VMS Rehab Systems, Inc. | 133.52 USD | -919712302.636% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -83608.305% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -194536.712% |
| Odyssey Group International, Inc. | 2.1 Million USD | -58159.935% |
| United American Healthcare Corporation | -9.32 Million USD | 13266.077% |
| ECGI Holdings, Inc. | 3.17 Million USD | -38622.987% |
| Capital Group Holdings, Inc. | -3508.00 USD | 35005801.254% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -467499.327% |
| Urologix, Inc. | 4.61 Million USD | -26508.884% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -29072.644% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -36763.073% |
| SS Innovations International, Inc. | 1.18 Million USD | -103498.53% |
| Qualis Innovations, Inc. | 6671.00 USD | -18407934.777% |
| Smith & Nephew plc | 2.77 Billion USD | 55.797% |
| NIOX Group Plc | -23.93 Million USD | 5231.119% |
| Fuse Medical, Inc. | 1.75 Million USD | -69851.78% |
| Broncus Holding Corporation | -81.42 Million USD | 1608.138% |
| Brain Scientific Inc. | 2.11 Million USD | -57940.308% |
| Pressure BioSciences, Inc. | 22.67 Million USD | -5315.157% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -3104281.02% |